IMAX Corporation
NYSE:IMAXEntertainment
+$0.46 today
- Market cap
- $2.58B
- Beta
- 0.37
- P/E (TTM)
- 65.9
- EPS (TTM)
- $0.68
Volume 0.95M
Average 1.13M
IMAX Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
IMAX CorporationNYSE: IMAX
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue growth accelerates
Q3 FY2026 cost of revenue of $48.25M rose 22.5% year over year, ahead of the +14.1% change in trailing-twelve-month cost of revenue. Sequentially, it rose 20.8% from the prior quarter. Over 3 fiscal years it compounded at +6.1% a year.
Context
- Cost of revenue amounted to 42.1% of revenue in FY2025, down 3.9 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +22.5% holds above the trailing-twelve-month pace of +14.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 172.64M USD
- Year-over-year change
- +6.6%
- 4-year CAGR
- +9.4%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 172.64M | +6.6% |
| FY2024 | 2024-12-31 | 162.01M | +0.9% |
| FY2023 | 2023-12-31 | 160.5M | +11.1% |
| FY2022 | 2022-12-31 | 144.45M | +19.9% |
| FY2021 | 2021-12-31 | 120.48M | — |
Cost of Revenue vs competitors
How IMAX compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +14.1% is the highest of 9, against a peer median of -7.3%.
- Cost of revenue amounts to 37.0% of revenue for IMAX, versus a peer median of 54.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CN¥3.01B CNY | -82.4% | -1.2% | 81.2% | |
| LTM Mar 2026 | $1.95B USD | +10.9% | +6.2% | 53.2% | |
| LTM Jun 2026 | $1.74B USD | -28.9% | -10.5% | 60.4% | |
| LTM Jun 2026 | $1.72B USD | +4.3% | +7.8% | 32.9% | |
| LTM Jun 2026 | $582.3M USD | +13.6% | +5.2% | 54.9% | |
| LTM Jul 2026 | $409.91M USD | -15.2% | -17.8% | 24.6% | |
| LTM Sep 2026 | $217.65M USD | -52.6% | -26.8% | 24.1% | |
| LTM Sep 2026 | $178.87M USD | +14.1% | +6.1% | 37.0% | |
| LTM Jun 2026 | $11.09M USD | +0.7% | +11.3% | 278.7% | |
| Peer median (excluding IMAX) | — | -7.3% | +2.0% | 54.1% | |
Competitors are the stored peer set for IMAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 254.88M | 300.81M | 374.84M | 352.21M | 410.21M |
| Cost of Revenue | 120.48M | 144.45M | 160.5M | 162.01M | 172.64M |
| Gross Profit | 134.41M | 156.36M | 214.34M | 190.2M | 237.57M |
| Gross Margin | 52.7% | 52.0% | 57.2% | 54.0% | 57.9% |
| Research & Development | 6.94M | 5.3M | 10.11M | 5.1M | 4.12M |
| Selling, General & Admin | 117.79M | 138.04M | 144.41M | 132.7M | 137.85M |
| Operating Expenses | 123.42M | 161.19M | 163.94M | 146.34M | 141.97M |
| Depreciation & Amortization | 56.08M | 56.66M | 60.02M | 65.5M | 62.45M |
| EBITDA | 74.16M | 52.77M | 112.96M | 111.29M | 133.1M |
| EBITDA Margin | 29.1% | 17.5% | 30.1% | 31.6% | 32.4% |
| Operating Income | 10.98M | (4.83M) | 50.4M | 43.86M | 95.6M |
| Operating Margin | 4.3% | -1.6% | 13.4% | 12.5% | 23.3% |
| Interest Income | 2.22M | 1.43M | 2.49M | 2.18M | 2.8M |
| Interest Expense | 7.09M | 5.88M | 6.82M | 8.08M | 7.36M |
| Other Income / Expenses | 3K | (4.94M) | (4.28M) | (6.16M) | (32.31M) |
| Income Before Tax | 10.99M | (9.77M) | 46.12M | 37.7M | 63.29M |
| Pre-Tax Margin | 4.3% | -3.2% | 12.3% | 10.7% | 15.4% |
| Income Tax Expense | 20.56M | 10.11M | 13.05M | 5M | 17.77M |
| Net Income | (22.33M) | (22.8M) | 25.34M | 26.06M | 34.88M |
| Net Margin | -8.8% | -7.6% | 6.8% | 7.4% | 8.5% |
| EPS (Basic) | (0.38) | (0.40) | 0.47 | 0.49 | 0.65 |
| EPS (Diluted) | (0.38) | (0.40) | 0.46 | 0.48 | 0.63 |
| Weighted Avg Shares | 59.13M | 56.67M | 54.31M | 52.65M | 53.64M |
| Weighted Avg Shares (Diluted) | 59.13M | 56.67M | 55.15M | 53.86M | 55.54M |
IMAX Corporation
NYSE:IMAX
Intrinsic Alpha fair value
Locked
Current Price
$46.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.